Wellness Index Report, an independent wellness ratings and education platform founded by Lindsay O'Neill-O’Keefe, has published a new Inside the Index feature spotlighting Nefense, a company helping redefine modern nasal wellness through innovative hypochlorous acid (HOCl) and xylitol-based products. The full announcement includes details on the recognition.
The article reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. According to Wellness Index Report, Nefense offers doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to OTC sprays. These products were formulated under the direction of Dr. Richard Downs, DDS.
The recognition underscores growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care. Nefense's HOCl and xylitol-based formulations are positioned to address a range of nasal and respiratory concerns without the side effects associated with some over-the-counter medications.
Wellness Index Report is an independent health and wellness education platform dedicated to helping consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. Through its Inside the Index editorial series, the organization highlights companies, practitioners, and technologies shaping the future of wellness and longevity.
For more information about Nefense and its products, readers can refer to the full Wellness Index Report feature. The recognition reflects a broader shift toward natural, drug-free options in personal health and wellness, particularly in the context of increasing awareness about respiratory health.
